Cellenkos scores FDA orphan drug designation for CK0804 in rare blood cancer
Receiving Orphan Drug Designation is an important milestone in the clinical development of CK0804 for myelofibrosis
Receiving Orphan Drug Designation is an important milestone in the clinical development of CK0804 for myelofibrosis
Sovaaka offers a deeply personalised diagnostics-led wellness experience that goes beyond routine health checks
The work will leverage ProBioGen’s CHO.RiGHT expression platform, powered by its proprietary DirectedLuck transposase technology, alongside PsiBot smart automation
Fasting glucose improved by 12.3 mg/dL, while liver stiffness dropped 23.7%, signaling a direct hepatic benefit
The SNS records neural activity from 60 channels across four brain regions—far exceeding current commercial devices
He noted the enduring relevance of Siddha medicine as “a comprehensive, preventive and sustainable healthcare system in the contemporary world
Leaders from science, policy, industry, and investment came together in New Delhi to examine how alignment across the biotechnology value chain can turn innovation into outcomes at scale
The acquisition adds HLD-0915, a once-daily oral therapy for prostate cancer, to Johnson & Johnson’s nearly 20-year legacy of innovation in the disease
Transcenta will grant EirGenix a non-exclusive license to its Highly Intensified Continuous Bioprocessing (HiCB) platform
The partnership also sets the stage for broader collaboration on rare disease treatments
Subscribe To Our Newsletter & Stay Updated